Australia markets close in 5 hours 10 minutes

Novavax, Inc. (NVAX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
5.78-0.24 (-3.99%)
At close: 04:00PM EDT
5.85 +0.07 (+1.21%)
After hours: 07:53PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close6.02
Bid5.80 x 1200
Ask5.90 x 3200
Day's range5.77 - 6.16
52-week range5.68 - 83.54
Avg. volume6,824,111
Market cap498.081M
Beta (5Y monthly)1.78
PE ratio (TTM)N/A
EPS (TTM)-8.52
Earnings date08 May 2023 - 12 May 2023
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est50.80
  • Motley Fool

    1 Green Flag and 1 Red Flag for Novavax

    Novavax (NASDAQ: NVAX) has had more than its share of ups and downs over the past few years -- and investors have been along for the ride. The stock soared 2,700% in 2020 as the company brought its coronavirus vaccine candidate through late-stage clinical trials. The biotech company's vaccine reached commercialization later than rivals.

  • Zacks

    Novavax (NVAX) Gains But Lags Market: What You Should Know

    Novavax (NVAX) closed at $5.97 in the latest trading session, marking a +1.19% move from the prior day.

  • Motley Fool

    2 Growth Stocks That Are Trading at a Huge Discount Right Now -- Maybe Rightfully So

    On that note, here are a couple of severely beaten-down growth stocks that are popular among investors, but only one of them has a credible path to stay in business. With ambitions to become the world's biggest seller of legal cannabis products, Tilray Brands (NASDAQ: TLRY) is also a growth stock that's remarkably inexpensive. Despite reporting $144 million in revenue for its fiscal second quarter and free cash flow (FCF) of $25.4 million, its shares are down 42.7% in the last three years because of persistent unprofitability and wild oversupply compared to demand across several continents.